Common Outcome Measures for AD Lack Adequate Reporting of Race
Many validation studies of clinician- and patient-reported outcome measures for atopic dermatitis (AD) lack adequate reporting of race, ethnicity, and […]
Many validation studies of clinician- and patient-reported outcome measures for atopic dermatitis (AD) lack adequate reporting of race, ethnicity, and […] (Reuters) – AbbVie Inc and Eli Lilly & Co are facing fresh delays in the approval of their respective rheumatoid […] Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Two recent articles in the medical […] Throughout the course of the COVID-19 pandemic, those able to wear a face mask have been encouraged to do so […] Eczema is a general term for itchy, dry skin conditions and the most common is atopic eczema, also known as […]dermatitis
Common Outcome Measures for AD Lack Adequate Reporting of Race
AbbVie, Lilly Face Fresh Delays in FDA Approval for Expanded Use of Arthritis Drugs
COVID-19-Related Skin Manifestations in Children Continue to Emerge
Some allergens that cause contact dermatitis are found in masks that prevent COVID-19
Eczema treatment: Eliminating this from your diet may lead to skin improvements
Copyright © 2024